Skip to main content

MoneyWorks4Me

Strides Pharma Science informs about press release

14 Nov 2022 Evaluate

Strides Pharma Science has informed that it attached Press Release issued by the Company titled: ‘Stelis receives a positive recommendation from European Medicines Agency (EMA) granting market authorization for KaulivTM, a recombinant human teriparatide biosimilar to treat osteoporosis’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..